• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大数据治理需要更多的集体责任:减轻危害在医学及其他领域数据使用治理中的作用。

Big Data Governance Needs More Collective Responsibility: The Role of Harm Mitigation in the Governance of Data Use in Medicine and Beyond.

作者信息

McMahon Aisling, Buyx Alena, Prainsack Barbara

机构信息

Department of Law, Maynooth University, Maynooth, Ireland.

Institute of History and Ethics in Medicine, School of Medicine, Technische Universität München, Munich, Germany.

出版信息

Med Law Rev. 2020 Feb 1;28(1):155-182. doi: 10.1093/medlaw/fwz016.

DOI:10.1093/medlaw/fwz016
PMID:31377815
Abstract

Harms arising from digital data use in the big data context are often systemic and cannot always be captured by linear cause and effect. Individual data subjects and third parties can bear the main downstream costs arising from increasingly complex forms of data uses-without being able to trace the exact data flows. Because current regulatory frameworks do not adequately address this situation, we propose a move towards harm mitigation tools to complement existing legal remedies. In this article, we make a normative and practical case for why individuals should be offered support in such contexts and how harm mitigation tools can achieve this. We put forward the idea of 'Harm Mitigation Bodies' (HMBs), which people could turn to when they feel they were harmed by data use but do not qualify for legal remedies, or where existing legal remedies do not address their specific circumstances. HMBs would help to obtain a better understanding of the nature, severity, and frequency of harms occurring from both lawful and unlawful data use, and they could also provide financial support in some cases. We set out the role and form of these HMBs for the first time in this article.

摘要

在大数据背景下,数字数据使用所产生的危害往往具有系统性,并不总能通过线性的因果关系来把握。个体数据主体和第三方可能要承担日益复杂的数据使用形式所产生的主要下游成本,却无法追踪确切的数据流。由于当前的监管框架未能充分应对这种情况,我们建议转向危害减轻工具,以补充现有的法律补救措施。在本文中,我们从规范和实际的角度论证了为何在此类情况下应向个人提供支持,以及危害减轻工具如何能够做到这一点。我们提出了“危害减轻机构”(HMBs)的构想,当人们觉得自己因数据使用而受到伤害,但不符合法律补救条件,或者现有法律补救措施无法解决其具体情况时,可以求助于这些机构。危害减轻机构将有助于更好地了解合法和非法数据使用所造成危害的性质、严重程度和发生频率,在某些情况下还可以提供经济支持。在本文中,我们首次阐述了这些危害减轻机构的作用和形式。

相似文献

1
Big Data Governance Needs More Collective Responsibility: The Role of Harm Mitigation in the Governance of Data Use in Medicine and Beyond.大数据治理需要更多的集体责任:减轻危害在医学及其他领域数据使用治理中的作用。
Med Law Rev. 2020 Feb 1;28(1):155-182. doi: 10.1093/medlaw/fwz016.
2
Health Research with Big Data: Time for Systemic Oversight.大数据健康研究:进行系统性监督的时候了。
J Law Med Ethics. 2018 Mar;46(1):119-129. doi: 10.1177/1073110518766026. Epub 2018 Mar 27.
3
Publishing physician profiles: what's fair ?发布医生简介:何为公平?
Med Econ. 2004 Dec 17;81(24):16-9.
4
We need to think about data governance for dementia research in a digital era.我们需要在数字时代思考痴呆症研究的数据治理问题。
Alzheimers Res Ther. 2020 Jan 31;12(1):17. doi: 10.1186/s13195-020-0584-y.
5
The Ethics in Synthetics: Statistics in the Service of Ethics and Law in Health-Related Research in Big Data from Multiple Sources.合成物中的伦理:多源大数据健康相关研究中服务于伦理与法律的统计学
J Law Health. 2018;31(1):87-117.
6
Tuberculosis结核病
7
Legal issues concerning electronic health information: privacy, quality, and liability.电子健康信息的法律问题:隐私、质量与责任。
JAMA. 1999 Oct 20;282(15):1466-71. doi: 10.1001/jama.282.15.1466.
8
FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.美国食品药品监督管理局扩大上市后监管权限以监测并公布食品及消费品健康风险:在9·11后的监管环境中,需要程序保障措施来减少“透明度”政策带来的危害
Food Drug Law J. 2009;64(3):577-98.
9
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.综合护理路径在医疗环境中对成人和儿童的有效性:一项系统评价。
JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001.
10
Confidentiality in medicine: how far should doctors prioritise the confidentiality of the individual they are treating?医学保密:医生应在多大程度上优先考虑他们正在治疗的个体的保密性?
Postgrad Med J. 2018 Oct;94(1116):596-600. doi: 10.1136/postgradmedj-2018-136038. Epub 2018 Nov 13.

引用本文的文献

1
AI-assisted facial analysis in healthcare: From disease detection to comprehensive management.医疗保健中的人工智能辅助面部分析:从疾病检测到综合管理。
Patterns (N Y). 2025 Feb 4;6(2):101175. doi: 10.1016/j.patter.2025.101175. eCollection 2025 Feb 14.
2
Ethical and social implications of public-private partnerships in the context of genomic/big health data collection.公共-私营伙伴关系在基因组/大健康数据收集方面的伦理和社会影响。
Eur J Hum Genet. 2024 Jun;32(6):736-741. doi: 10.1038/s41431-024-01608-9. Epub 2024 Apr 16.
3
Non-fungible tokens in healthcare: a scoping review.
医疗保健中的非同质化代币:范围综述。
Front Public Health. 2023 Nov 21;11:1266385. doi: 10.3389/fpubh.2023.1266385. eCollection 2023.
4
The European health data space: Too big to succeed?欧洲健康数据空间:太大而难以成功?
Health Policy. 2023 Sep;135:104861. doi: 10.1016/j.healthpol.2023.104861. Epub 2023 Jun 26.
5
Normative positions towards COVID-19 contact-tracing apps: findings from a large-scale qualitative study in nine European countries.对新冠病毒接触者追踪应用程序的规范性立场:来自九个欧洲国家的大规模定性研究结果
Crit Public Health. 2021 Jun 2;32(1):5-18. doi: 10.1080/09581596.2021.1925634. eCollection 2022.
6
Patient data for commercial companies? An ethical framework for sharing patients' data with for-profit companies for research.商业公司获取患者数据?关于与营利性公司共享患者数据用于研究的伦理框架。
J Med Ethics. 2025 Apr 24;51(5):jme-2022-108781. doi: 10.1136/jme-2022-108781.
7
Do genomic passports leave us more vulnerable or less vulnerable? Perspectives from an online citizen engagement.基因护照会让我们变得更易受伤害还是更不易受伤害?来自在线公民参与的观点。
Humanit Soc Sci Commun. 2023;10(1):83. doi: 10.1057/s41599-023-01580-7. Epub 2023 Mar 4.
8
The ethical and legal landscape of brain data governance.脑数据治理的伦理和法律格局。
PLoS One. 2022 Dec 29;17(12):e0273473. doi: 10.1371/journal.pone.0273473. eCollection 2022.
9
Motives for withdrawal of participation in biobanking and participants' willingness to allow linkages of their data.参与生物银行研究的退出动机及参与者允许其数据关联的意愿。
Eur J Hum Genet. 2022 Mar;30(3):367-377. doi: 10.1038/s41431-021-00997-5. Epub 2021 Nov 22.
10
The Challenges of Big Data for Research Ethics Committees: A Qualitative Swiss Study.大数据对研究伦理委员会的挑战:瑞士的定性研究
J Empir Res Hum Res Ethics. 2022 Feb-Apr;17(1-2):129-143. doi: 10.1177/15562646211053538. Epub 2021 Nov 15.